Mithra Pharmaceuticals Liabilities 2024

Mithra Pharmaceuticals Aktienanalyse

What does Mithra Pharmaceuticals do?

Mithra Pharmaceuticals SA is a Belgian pharmaceutical company specializing in women's health and hormone therapy. The company was founded in 1999 by François Fornieri and Jean-Michel Foidart and has since become a major player in women's healthcare. Its unique business model covers the entire value chain of the pharmaceutical industry, including research and development, production, distribution, and marketing of its own products. Mithra Pharmaceuticals SA collaborates with other pharmaceutical companies, universities, and public research institutions worldwide, aiming to offer innovative products and services based on new technologies and scientific knowledge. The company's divisions include hormone therapy, contraception, gynecology, and dermatology, providing a wide range of products and services tailored to women's needs. One of its notable products is the Estetrol patch, a safe and effective contraceptive containing a natural estrogen hormone produced during pregnancy. In gynecology, Mithra Pharmaceuticals SA offers products for the treatment of menstrual disorders, endometriosis, and vaginal dryness, such as the Estelle pill concept, which combines contraception and hormone regulation. In dermatology, the company provides skincare products based on natural ingredients, specifically designed for women with sensitive skin or skin issues. Overall, Mithra Pharmaceuticals SA focuses on meeting the needs of women and has a history of adapting to market conditions and offering innovative products and services. With its global presence and innovative products, Mithra Pharmaceuticals SA is well-positioned for future success. Mithra Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Mithra Pharmaceuticals's Liabilities

Mithra Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Mithra Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Mithra Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Mithra Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Mithra Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Mithra Pharmaceuticals stock

What is the level of liabilities of Mithra Pharmaceuticals this year?

Mithra Pharmaceuticals has a debt balance of 0 EUR this year.

What were the liabilities of Mithra Pharmaceuticals compared to the previous year?

The liabilities of Mithra Pharmaceuticals have increased by -100% dropped compared to the previous year.

What are the consequences of high debt for investors of Mithra Pharmaceuticals?

High liabilities can pose a risk for investors of Mithra Pharmaceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Mithra Pharmaceuticals?

Low liabilities mean that Mithra Pharmaceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Mithra Pharmaceuticals affect the company?

An increase in liabilities of Mithra Pharmaceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Mithra Pharmaceuticals affect the company?

A decrease in the liabilities of Mithra Pharmaceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Mithra Pharmaceuticals?

Some factors that can influence the liabilities of Mithra Pharmaceuticals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Mithra Pharmaceuticals so important for investors?

The liabilities of Mithra Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Mithra Pharmaceuticals take to modify the liabilities?

To change its liabilities, Mithra Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Mithra Pharmaceuticals pay?

Over the past 12 months, Mithra Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mithra Pharmaceuticals is expected to pay a dividend of 0 EUR.

What is the dividend yield of Mithra Pharmaceuticals?

The current dividend yield of Mithra Pharmaceuticals is .

When does Mithra Pharmaceuticals pay dividends?

Mithra Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Mithra Pharmaceuticals?

Mithra Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Mithra Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Mithra Pharmaceuticals located?

Mithra Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mithra Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mithra Pharmaceuticals from 10/6/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/6/2024.

When did Mithra Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/6/2024.

What was the dividend of Mithra Pharmaceuticals in the year 2023?

In the year 2023, Mithra Pharmaceuticals distributed 0 EUR as dividends.

In which currency does Mithra Pharmaceuticals pay out the dividend?

The dividends of Mithra Pharmaceuticals are distributed in EUR.